Nasdaq News

(RTTNews) - Huntington Ingalls Industries, Inc. (HII), a military shipbuilder, Tuesday announced that its Newport News Shipbuilding division has secured a $5.09 billion contract for the refueling and complex overhaul or RCOH of nuclear-powered aircraft carrier USS Harry S. Truman

(RTTNews) - DBV Technologies (DBVT) announced that it has submitted a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch in children aged 4 through 7 years with peanut allergy. The company has requested Priority Review of the application.

(RTTNews) - Larimar Therapeutics, Inc. (LRMR), a clinical-stage biotechnology company, announced the appointment of John Harlow as President and Chief Operating Officer, effective September 29, 2026. He will report to Carole Ben-Maimon, Larimar's Chief Executive Officer.

(RTTNews) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning IMVEXXY (estradiol vaginal inserts) and its U.S. FDA Orange Book-listed patents.

(RTTNews) - Eli Lilly and Company (LLY) announced detailed results from the Phase 3 TRIUMPH-2 study showing that retatrutide delivered substantial weight loss and blood sugar improvements in adults living with obesity or overweight and type 2 diabetes.

Soybeans are showing 10 to 13 cent gains so far on Tuesday trade. The cmdtyView national average Cash Bean price is up 13 1/4 cents at $12.46 3/4. Soymeal futures are up $2.30 to $2.90, with Soy Oil slipping just 85 to 93 points. USDA’s Crop Progress report from Monday...

(RTTNews) - Eli Lilly and Company (LLY) reported detailed Phase 3 TRIUMPH-2 results showing that Retatrutide delivered substantial weight loss and blood sugar reductions in adults with obesity or overweight and type 2 diabetes.

Key PointsThe transaction involved 3,300 shares executed at a weighted average price of $296.58, totaling ~$979,000.

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) announced positive topline results from its pivotal Phase 3 study of HETLIOZ (tasimelteon) in adults with Delayed Sleep-Wake Phase Disorder, a circadian rhythm disorder that causes people to fall asleep and wake much later than desire

AT&T (NYSE: T) and Verizon (NYSE: VZ) pay attractive dividends, which are catching the attention of passive income investors.

The rising cost of living is putting consumer balance sheets under pressure, which is increasing the risk that people will default on their loans.

A business with a moat becomes an increasingly attractive stock when considering investing for the very long term.

AT&T (NYSE: T) is not going to double your money overnight, but it has the potential to deliver reasonable shareholder returns in the long run.

Duolingo (NASDAQ: DUOL) is prioritizing customer growth over monetization.

Sales are growing for these two semiconductor companies as demand for AI booms.

The healthcare industry is being overlooked by investors who are primarily focused on artificial intelligence.

Starbucks (NASDAQ: SBUX) is closing 250 stores, which has significant implications for investors.

Grand Theft Auto 6 is arguably the most anticipated launch in gaming history.

Key PointsInvestors have been concerned about weakening engagement at Netflix.

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) boasts several products with over one billion monthly active users.